News
Further data could back zanidatamab as advanced treatment for HER2-positive advanced gastroesophageal adenocarcinoma.
Panelists discuss how comprehensive patient education about expected adverse effects, combined with prophylactic measures ...
Extended oral antibiotic prophylaxis eliminated UTIs after robot-assisted radical cystectomy procedures. Prophylactic ...
The FDA has approved garadacimab-gxii for prophylactic use in patients aged 12 years and older with hereditary angioedema, ...
A panelist discusses the evolving role of prophylactic tocilizumab in reducing cytokine release syndrome during bispecific ...
New FRONTIER5 results show a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for a washout period, was well-tolerated in adults and ...
New FRONTIER5 results show a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for a washout period, was well-tolerated in adults and ...
Novo Nordisk today presented results from the phase 3b FRONTIER5 trial showing that a direct switch to investigational Mim8 (denecimig) prophylaxis from emicizumab treatment, without a washout ...
Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the ISTH 2025 Congress Mim8 prophylaxis treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results